Baxter announces u.s. fda de novo authorization for theranova dialyzers enabling hdx therapy

Baxter announces u.s. fda de novo authorization for theranova dialyzers enabling hdx therapy.baxter international inc - u.s. patients with kidney failure now have access to expanded hdx therapy delivered by theranova.
BAX Ratings Summary
BAX Quant Ranking